Insider Trading activities of Versartis, Inc. insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Versartis, Inc. since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Versartis, Inc. since year 2005. Table 2 shows the detailed insider transactions of Versartis, Inc. since 2005. The reporting company's ticker symbol is VSAR. The reporting company's CIK number is 1513818.
The total value of stock buying since 2005 is $36,307,465.
The total value of stock sales since 2005 is $49,136,308.
The total value of stock option exercises since 2005 is $659,497.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Versartis, Inc. (VSAR).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-12 976,467 $2,115,408 0 $0 0 $0
2017-10 0 $0 4,095 $10,440 0 $0
2017-09 0 $0 2,130,000 $7,001,130 0 $0
2017-06 0 $0 2,132 $34,218 0 $0
2017-05 0 $0 1,263 $21,976 0 $0
2017-04 0 $0 36,316 $768,122 35,000 $285,950
2017-03 571,429 $7,000,005 652,041 $11,973,448 0 $0
2017-02 239,839 $3,439,963 108,934 $2,107,444 99,408 $222,748
2017-01 0 $0 66,767 $978,423 53,758 $100,968
2016-12 142,125 $2,069,434 10,872 $155,872 5,000 $6,324
2016-10 571,429 $7,000,005 0 $0 0 $0
2016-08 0 $0 7,042 $90,847 0 $0
2016-06 0 $0 2,173 $23,098 0 $0
2016-05 0 $0 1,265 $9,955 0 $0
2016-04 0 $0 1,430 $13,842 0 $0
2015-12 0 $0 1,352 $16,812 0 $0
2015-11 12,500 $126,575 0 $0 0 $0
2015-08 0 $0 2,400 $44,136 2,400 $3,035
2015-07 0 $0 2,400 $36,000 2,400 $3,035
2015-06 0 $0 2,400 $40,142 2,400 $3,035
2015-05 0 $0 2,400 $41,930 2,400 $3,035
2015-04 0 $0 10,400 $203,011 2,400 $3,035
2015-03 0 $0 18,400 $370,574 2,400 $3,035
2015-02 0 $0 13,000 $250,576 5,000 $6,324
2015-01 405,500 $6,994,875 13,000 $291,750 5,000 $6,324
2014-12 0 $0 172,000 $3,293,308 10,000 $12,649
2014-11 0 $0 1,093,000 $21,107,921 0 $0
2014-09 0 $0 12,556 $251,333 0 $0
2014-03 360,000 $7,561,200 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Versartis, Inc. insiders (VSAR)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-12-05 Akkaraju Srinivas (Director) Buy 42,895 2.00 85,790
2017-12-04 Akkaraju Srinivas (Director) Buy 513,872 2.21 1,135,657
2017-12-01 Akkaraju Srinivas (Director) Buy 419,700 2.13 893,961
2017-10-19 Ward Shane (SVP and General Counsel) Sale 776 2.55 1,978
2017-10-19 Westberg Paul (SVP and Chief Business Officer) Sale 1,326 2.55 3,381
2017-10-19 Brumm Joshua T (COO and CFO) Sale 1,326 2.55 3,381
2017-10-19 Hislop Colin (Chief Medical Officer) Sale 667 2.55 1,700
2017-09-22 Edelman Joseph (10% Owner) Sale 1,650,000 3.18 5,248,650
2017-09-21 Edelman Joseph (10% Owner) Sale 480,000 3.65 1,752,480
2017-06-13 Westberg Paul (SVP and Chief Business Officer) Sale 711 16.05 11,411
2017-06-13 Brumm Joshua T (COO and CFO) Sale 1,421 16.05 22,807
2017-05-16 Brumm Joshua T (COO and CFO) Sale 1,263 17.40 21,976
2017-04-19 Westberg Paul (SVP and Chief Business Officer) Sale 1,316 19.85 26,122
2017-04-04 Hislop Colin (Chief Medical Officer) Sale 35,000 21.20 742,000
2017-04-04 Hislop Colin (Chief Medical Officer) Option Ex 35,000 8.17 285,950
2017-03-24 Akkaraju Srinivas (Director) Buy 571,429 12.25 7,000,005
2017-03-17 Malik Shahzad (Director) Sale 386,367 18.01 6,958,469
2017-03-16 Malik Shahzad (Director) Sale 97,303 18.50 1,800,105
2017-03-15 Ward Shane (SVP and General Counsel) Sale 776 19.02 14,759
2017-03-15 Malik Shahzad (Director) Sale 103,122 19.08 1,967,567
2017-03-14 Ward Shane (SVP and General Counsel) Sale 1,265 19.00 24,035
2017-03-14 Malik Shahzad (Director) Sale 46,878 19.02 891,385
2017-03-13 Malik Shahzad (Director) Sale 16,330 19.42 317,128
2017-02-27 Westberg Paul (SVP and Chief Business Officer) Sale 12,500 22.50 281,250
2017-02-27 Westberg Paul (SVP and Chief Business Officer) Option Ex 12,500 2.07 25,874
2017-02-27 Shepard Jay (President and CEO) Sale 5,166 24.00 123,984
2017-02-27 Shepard Jay (President and CEO) Option Ex 5,166 2.53 13,069
2017-02-24 Brumm Joshua T (COO and CFO) Sale 30,000 21.31 639,300
2017-02-24 Brumm Joshua T (COO and CFO) Option Ex 30,000 2.53 75,900
2017-02-23 Westberg Paul (SVP and Chief Business Officer) Sale 6,590 20.00 131,800
2017-02-23 Westberg Paul (SVP and Chief Business Officer) Option Ex 6,590 1.61 10,609
2017-02-23 Shepard Jay (President and CEO) Sale 8,000 20.00 160,000
2017-02-23 Shepard Jay (President and CEO) Option Ex 8,000 2.53 20,240
2017-02-21 Westberg Paul (SVP and Chief Business Officer) Sale 18,410 18.75 345,187
2017-02-21 Westberg Paul (SVP and Chief Business Officer) Option Ex 18,410 1.61 29,640
2017-02-21 Shepard Jay (President and CEO) Sale 8,000 18.50 148,000
2017-02-21 Shepard Jay (President and CEO) Option Ex 8,000 2.53 20,240
2017-02-13 Perceptive Life Sciences Master Fund Ltd Buy 59,133 15.52 917,448
2017-02-10 Perceptive Life Sciences Master Fund Ltd Buy 34,883 14.94 521,291
2017-02-09 Perceptive Life Sciences Master Fund Ltd Buy 41,211 14.27 587,916
2017-02-08 Perceptive Life Sciences Master Fund Ltd Buy 104,612 13.51 1,413,308
2017-02-03 Shepard Jay (President and CEO) Sale 6,719 13.69 91,983
2017-02-02 Shepard Jay (President and CEO) Sale 6,973 13.51 94,205
2017-02-02 Shepard Jay (President and CEO) Option Ex 4,166 2.53 10,539
2017-02-01 Shepard Jay (President and CEO) Sale 6,576 13.95 91,735
2017-02-01 Shepard Jay (President and CEO) Option Ex 6,576 2.53 16,637
2017-01-31 Shepard Jay (President and CEO) Sale 10,662 13.78 146,922
2017-01-31 Shepard Jay (President and CEO) Option Ex 10,662 2.53 26,974
2017-01-30 Ward Shane (SVP and General Counsel) Sale 1,474 13.85 20,417
2017-01-30 Westberg Paul (SVP and Chief Business Officer) Sale 1,916 13.85 26,540
2017-01-30 Shepard Jay (President and CEO) Sale 17,270 13.58 234,526
2017-01-30 Shepard Jay (President and CEO) Option Ex 10,596 2.53 26,807
2017-01-30 Brumm Joshua T (COO and CFO) Sale 2,945 13.85 40,794
2017-01-11 Westberg Paul (Sr. VP, Corporate Development) Sale 7,931 15.24 120,868
2017-01-11 Westberg Paul (Sr. VP, Corporate Development) Option Ex 7,931 1.61 12,768
2017-01-10 Westberg Paul (Sr. VP, Corporate Development) Sale 11,213 15.66 175,595
2017-01-10 Westberg Paul (Sr. VP, Corporate Development) Option Ex 11,213 1.50 16,763
2017-01-09 Westberg Paul (Sr. VP, Corporate Development) Sale 13,356 15.93 212,761
2017-01-09 Westberg Paul (Sr. VP, Corporate Development) Option Ex 13,356 1.32 17,656
2016-12-30 Perceptive Life Sciences Master Fund Ltd Buy 94,750 14.66 1,388,845
2016-12-29 Perceptive Life Sciences Master Fund Ltd Buy 47,375 14.37 680,589
2016-12-27 Westberg Paul (Sr. VP, Corporate Development) Sale 361 15.85 5,721
2016-12-27 Brumm Joshua T (Chief Financial Officer) Sale 990 15.85 15,691
2016-12-16 Westberg Paul (Sr. VP, Corporate Development) Sale 5,000 15.00 75,000
2016-12-16 Westberg Paul (Sr. VP, Corporate Development) Option Ex 5,000 1.26 6,324
2016-12-08 Jennings Edmon R (Director) Sale 1,500 12.96 19,432
2016-12-07 Brumm Joshua T (Chief Financial Officer) Sale 3,021 13.25 40,028
2016-10-03 Akkaraju Srinivas (Director) Buy 571,429 12.25 7,000,005
2016-08-25 Varian John (Director) Sale 1,600 12.97 20,755
2016-08-22 Shepard Jay (President and CEO) Sale 5,442 12.88 70,092
2016-06-15 Westberg Paul (Sr. VP, Business Development) Sale 725 10.63 7,706
2016-06-15 Brumm Joshua T (Chief Financial Officer) Sale 1,448 10.63 15,392
2016-05-20 Brumm Joshua T (Chief Financial Officer) Sale 1,265 7.87 9,955
2016-04-21 Westberg Paul (Sr. VP, Business Development) Sale 1,430 9.68 13,842
2015-12-30 Westberg Paul (Sr. VP, Business Development) Sale 362 12.44 4,501
2015-12-30 Brumm Joshua T (Chief Financial Officer) Sale 990 12.44 12,311
2015-11-12 Brumm Joshua T (Chief Financial Officer) Buy 2,500 9.99 24,975
2015-11-11 Greer R Scott (Director) Buy 10,000 10.16 101,600
2015-08-04 Westberg Paul (Sr. VP, Business Development) Sale 2,400 18.39 44,136
2015-08-04 Westberg Paul (Sr. VP, Business Development) Option Ex 2,400 1.26 3,035
2015-07-06 Westberg Paul (Sr. VP, Business Development) Sale 2,400 15.00 36,000
2015-07-06 Westberg Paul (Sr. VP, Business Development) Option Ex 2,400 1.26 3,035
2015-06-03 Westberg Paul (Sr. VP, Business Development) Sale 2,400 16.73 40,142
2015-06-03 Westberg Paul (Sr. VP, Business Development) Option Ex 2,400 1.26 3,035
2015-05-04 Westberg Paul (Sr. VP, Business Development) Sale 2,400 17.47 41,930
2015-05-04 Westberg Paul (Sr. VP, Business Development) Option Ex 2,400 1.26 3,035
2015-04-14 Cleland Jeffrey L (President and CEO) Sale 8,000 20.13 161,040
2015-04-06 Westberg Paul (Sr. VP, Business Development) Sale 2,400 17.49 41,971
2015-04-06 Westberg Paul (Sr. VP, Business Development) Option Ex 2,400 1.26 3,035
2015-03-23 Cleland Jeffrey L (President and CEO) Sale 4,000 20.26 81,028
2015-03-20 Cleland Jeffrey L (President and CEO) Sale 740 20.07 14,849
2015-03-19 Cleland Jeffrey L (President and CEO) Sale 1,315 20.01 26,311
2015-03-18 Cleland Jeffrey L (President and CEO) Sale 1,124 20.03 22,514
2015-03-17 Cleland Jeffrey L (President and CEO) Sale 738 20.09 14,827
2015-03-16 Cleland Jeffrey L (President and CEO) Sale 83 20.02 1,661
2015-03-10 Cleland Jeffrey L (President and CEO) Sale 2,537 20.30 51,501
2015-03-09 Cleland Jeffrey L (President and CEO) Sale 1,463 20.10 29,410
2015-03-03 Westberg Paul (Sr. VP, Business Development) Sale 2,400 20.03 48,069
2015-03-03 Westberg Paul (Sr. VP, Business Development) Option Ex 2,400 1.26 3,035
2015-03-03 Cleland Jeffrey L (President and CEO) Sale 1,129 20.07 22,657
2015-03-02 Cleland Jeffrey L (President and CEO) Sale 2,871 20.11 57,747
2015-02-25 Cleland Jeffrey L (President and CEO) Sale 8,000 20.25 161,976
2015-02-03 Westberg Paul (Sr. VP, Business Development) Sale 5,000 17.72 88,600
2015-02-03 Westberg Paul (Sr. VP, Business Development) Option Ex 5,000 1.26 6,324
2015-01-27 Sun Anthony Y Buy 145,000 17.25 2,501,250
2015-01-27 Greer R Scott (Director) Buy 5,500 17.25 94,875
2015-01-27 Schiff Andrew N Buy 145,000 17.25 2,501,250
2015-01-22 Advent Life Sciences Fund I Lp (Other) Buy 55,000 17.25 948,750
2015-01-22 Malik Shahzad (Director) Buy 55,000 17.25 948,750
2015-01-12 Cleland Jeffrey L (President and CEO) Sale 4,000 22.86 91,420
2015-01-05 Westberg Paul (Sr. VP, Business Development) Sale 5,000 22.76 113,810
2015-01-05 Westberg Paul (Sr. VP, Business Development) Option Ex 5,000 1.26 6,324
2015-01-05 Cleland Jeffrey L (President and CEO) Sale 4,000 21.63 86,520
2014-12-29 Cleland Jeffrey L (President and CEO) Sale 4,000 22.11 88,420
2014-12-22 Cleland Jeffrey L (President and CEO) Sale 7,980 20.95 167,149
2014-12-19 Cleland Jeffrey L (President and CEO) Sale 20 20.00 400
2014-12-18 Ratcliffe Liam (10% Owner) Sale 150,000 19.01 2,851,800
2014-12-12 Westberg Paul (Sr. VP, Business Development) Sale 3,054 18.65 56,969
2014-12-12 Westberg Paul (Sr. VP, Business Development) Option Ex 3,054 1.26 3,863
2014-12-11 Westberg Paul (Sr. VP, Business Development) Sale 6,946 18.51 128,570
2014-12-11 Westberg Paul (Sr. VP, Business Development) Option Ex 6,946 1.26 8,786
2014-11-24 Yucca (jersey) Slp Sale 17,207 18.02 310,001
2014-11-21 Index Ventures Iv Parallel Entrepreneur Fund (jersey) Lp Sale 26,793 18.04 483,318
2014-11-20 Yucca (jersey) Slp Sale 9,000 18.32 164,889
2014-11-18 Yucca (jersey) Slp Sale 191,362 19.38 3,708,978
2014-11-13 Yucca (jersey) Slp Sale 12,438 19.43 241,695
2014-11-12 Yucca (jersey) Slp Sale 36,200 19.42 703,040
2014-11-11 Ratcliffe Liam (10% Owner) Sale 800,000 19.37 15,496,000
2014-09-29 Ratcliffe Liam (10% Owner) Sale 12,556 20.02 251,333
2014-03-27 Ratcliffe Liam (10% Owner) Buy 60,000 21.02 1,261,200
2014-03-26 Advent Life Sciences Fund I Lp (10% Owner) Buy 60,000 21.00 1,260,000
2014-03-26 Malik Shahzad (Director) Buy 60,000 21.00 1,260,000
2014-03-26 Sun Anthony Y (Director) Buy 60,000 21.00 1,260,000
2014-03-26 Powell Michael (10% Owner) Buy 60,000 21.00 1,260,000
2014-03-26 Schiff Andrew N (10% Owner) Buy 60,000 21.00 1,260,000

Insider trading activities including stock purchases, stock sales, and option exercises of VSAR listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Versartis, Inc. (symbol VSAR, CIK number 1513818) see the Securities and Exchange Commission (SEC) website.